MedTrace Logo

Growth and Tolerance of Hypoallergenic Formulas

NCT01354366 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 511

Last updated 2013-08-29

No results posted yet for this study

Summary

This clinical trial will evaluate two investigational hypoallergenic infant formulas with a differing protein content to determine if they provide normal growth and are well tolerated by term infants as compared to a marketed hypoallergenic formula.

Conditions

  • Growth of Term Infants

Interventions

OTHER

Infant formula

Sponsors & Collaborators

  • Mead Johnson Nutrition

    lead INDUSTRY

Principal Investigators

  • Timothy Cooper, M.D. · Mead Johnson Nutrition

Eligibility

Min Age
12 Days
Max Age
16 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01354366 on ClinicalTrials.gov